Health Invest Partners Ab Charles River Laboratories International, Inc. Transaction History

Health Invest Partners Ab

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 05, 2021	SELL	$222.0 - $252.62 $5.93 Million - $6.75 Million	-26,712 Closed	0 $0
Q4 2017 Feb 09, 2018	SELL	$100.43 - $118.09 $3.42 Million - $4.03 Million	-34,100 Reduced 56.07%	26,712 $2.92 Million
Q3 2017 Nov 13, 2017	SELL	$96.72 - $109.26 $909,168 - $1.03 Million	-9,400 Reduced 13.39%	60,812 $6.57 Million
Q2 2017 Aug 07, 2017	BUY	N/A	70,212	70,212 $7.1 Million

695

52.2M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.48B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Health Invest Partners Ab, based on Form 13F filings with the SEC.

Stay updated on Health Invest Partners Ab with notifications on news.